Firefly Neuroscience vs Immunarray
Firefly Neuroscience vs Immunarray, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Firefly Neuroscience is on 56/100 and Immunarray on 39/100.
Where each one leads
Firefly Neuroscience
- our overall score: 56/100 against 39/100
- agent readiness: 49/100 against 28/100
- domain rating: 38/100 against 18/100
- funding raised: $45.4M against $10.0M
Immunarray
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Firefly Neuroscience | Immunarray |
|---|---|---|
| What it is | Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology. | ImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform. |
| Category | Healthcare, Neurology, Mental Health, Brain EEG Injury | Healthcare, Blood, Diagnostics, Immunology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software, Hardware | Software |
| Founded | 2006 | 2006 |
| Headquarters | San Francisco, United States | Richmond, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Firefly Neuroscience | Immunarray |
|---|---|---|
| Employees | 25 | Not published |
| Headcount growthLast 12 months | -3.3% | Not published |
| Total funding | $45.4M | $10.0M |
| Latest round | Series C | Series A |
| LinkedIn followers | 8,237 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Firefly Neuroscience | Immunarray |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 39/100 |
| Traction | 52/100 | 35/100 |
| Team | 50/100 | 30/100 |
| Community | 8/100 | 13/100 |
| Search visibility | 25/100 | 5/100 |
| Quality | 62/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (49/100) | F (28/100) |
| Domain ratingLink authority, 0-100 | 38/100 | 18/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Firefly Neuroscience | Immunarray |
|---|---|---|
| Hosting | AWS | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4, Google Tag Manager | Not detected |
| Support stack | HubSpot | Not detected |
Firefly Neuroscience vs Immunarray: common questions
Which is better, Firefly Neuroscience or Immunarray?
On our 0-100 score Firefly Neuroscience rates higher (56/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Firefly Neuroscience and Immunarray compare on the numbers?
Firefly Neuroscience leads on our overall score (56/100 against 39/100), agent readiness (49/100 against 28/100), domain rating (38/100 against 18/100), funding raised ($45.4M against $10.0M).
Read the full Firefly Neuroscience review and pricing or the Immunarray review and pricing. You can also browse other Firefly Neuroscience alternatives we track.